Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant-Reference-Cited by-同舟云学术

Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant

Published:2006 Issue:7 Volume:47 Page:959-963
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Gilman Andrew L.,Serrano Amy,Skelley John,Zwick David

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference22 articles.

1. Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype

2. Zygomycetes in Human Disease

3. , . Mucorales. In: , editors. Fungi pathogenic for humans and animals. Part A: Biology. New York: Marcel Dekker; 1983. p 9–59.

4. In vitro susceptibilities of zygomycetes to conventional and new antifungals

5. Agents of mucormycosis and related species. In: , , editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, Vol. 2, 6th edition. Philadelphia, Pa: Churchill Livingstone; 2004. p 2973–2984.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome;Infection;2018-05-10

2. Mucormycosis treated with posaconazole: review of 96 case reports;Critical Reviews in Microbiology;2012-08-24

3. The Impact of the Host on Fungal Infections;The American Journal of Medicine;2012-01

4. Posaconazole for the treatment of mucormycosis;International Journal of Antimicrobial Agents;2011-12

5. Cavitary Pulmonary Zygomycosis Caused by Rhizopus homothallicus;Journal of Clinical Microbiology;2010-05